Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenTarget
San Diego, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
GenTarget Inc provides thousands of lentivirus and adenovirus products allowing gene modification, stable cell line creation, and molecular pathway research. Products are widely used across basic research, drug discovery, and bioscience research labs globally for over 15 years. No clinical trial data; products focused on research reagent market
- Therapeutic areas
- OncologyOtherRare Diseases
- Modalities
- LentivirusAdenovirusshRNA lentivirusmicroRNA lentivirusCRISPR gRNA lentivectorStable cell lineRecombinant proteinAntibody
- Industry
- Non-Drug Biotech
02
Partnerships
Wide distribution partnerships, e.g., Biolinkk (India)Krishgen Biosystems (India)
Beyond the preview
Go deeper on GenTarget.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GenTarget.